Clinical Validation of a Candidate Biomarker for Neurological Disease (U44 - Clinical Trial Optional)

The summary for the Clinical Validation of a Candidate Biomarker for Neurological Disease (U44 - Clinical Trial Optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Clinical Validation of a Candidate Biomarker for Neurological Disease (U44 - Clinical Trial Optional): The purpose of this Funding Opportunity Announcement (FOA) is encourage applications from Small Business Concerns (SBCs) to support rigorous clinical validation of a candidate biomarker using retrospective and/or prospective methods in a manner that is consistent with the purpose of the biomarker. This FOA assumes that: 1) a candidate biomarker has already been identified, 2) an analytical method has been developed and validated that is consistent with the purpose of the biomarker and 3) a working hypothesis regarding context of use is in place. The goal of this FOA is to facilitate the advancement of robust and reliable biomarkers of neurological disease for use in multi-site clinical trials and clinical practice.
Federal Grant Title: Clinical Validation of a Candidate Biomarker for Neurological Disease (U44 - Clinical Trial Optional)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-18-548
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.853
CFDA Descriptions: Information not provided
Current Application Deadline: September 7th, 2020
Original Application Deadline: September 7th, 2020
Posted Date: December 22nd, 2017
Creation Date: December 22nd, 2017
Archive Date: October 13th, 2020
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: December 22nd, 2017
Applicants Eligible for this Grant
Small businesses
Additional Information on Eligibility
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/pa-files/PAR-18-548.html
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Center without Walls for PET Ligand Development for Alzheimer's disease related dementias ...
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical ...
Lewy Body Dementia Center Without Walls (CWOW) (U54 Clinical Trial Not Allowed)
NINDS Morris K. Udall Center without Walls for Parkinsons Disease Research (P20 Clinical T...
NINDS Morris K. Udall Centers of Excellence for Parkinsons Disease Research (P50 Clinical ...
NINDS Cooperative Small Business Awards In Translational Research (SBIR/U44)
NINDS Institutional Center Core Grants to Support Neuroscience Research
Career Development Award to Promote Diversity in Neuroscience Research
More Grants from the National Institutes of Health
Womens HIV Epidemiology Cohort Studies (R01 Clinical Trial Not Allowed)
Summer Research Education Experience Program (Clinical Trials Not Allowed R25)
Virtual Reality Tools to Enhance Evidence Based Treatment of Substance Use Disorders (R41/...
Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors (U01 Clinica...
The Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Lab...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2019 FederalGrants.com